SPRINGFIELD, IL – Last night, the Illinois Senate passed Senate Bill 2679, improving access to recommended genetic testing and fact-based screenings for people with a personal or family history of cancer.
The following is a statement from Ally Lopshire, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Illinois:
"To reduce the burden of cancer in Illinois, ACS CAN supports legislation that will improve access to guideline recommended genetic testing for inherited gene mutations by capping burdensome patient cost-sharing requirements at no more than $50. We’re disappointed to see that the legislation allows for cost-sharing for evidence-based cancer screening, as cost is a known barrier to uptake of preventive services. However, this legislation would help ensure individuals have access to critical information regarding their cancer risk and the recommended cancer screenings based on that risk to catch possible cancer early.
"ACS CAN thanks Sen. Morrison for championing this effort and the Illinois Senate for approving this legislation. We urge the House to quickly follow suit and take this significant step towards improving health outcomes."
In 2024, approximately 23,280 Illinoisans will die from cancer. Improved access to genetic testing can give more patients the information they need to better understand their lifetime cancer risk and help make informed decisions regarding targeted prevention strategies.